BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 23856094)

  • 1. Thyroid nodule as a first manifestation of Hodgkin lymphoma-report of two cases and literature review.
    Szczepanek-Parulska E; Szkudlarek M; Majewski P; Breborowicz J; Ruchala M
    Diagn Pathol; 2013 Jul; 8():116. PubMed ID: 23856094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patients.
    Gharbaran R; Goy A; Tanaka T; Park J; Kim C; Hasan N; Vemulapalli S; Sarojini S; Tuluc M; Nalley K; Bhattacharyya P; Pecora A; Suh KS
    J Hematol Oncol; 2013 Aug; 6():62. PubMed ID: 23988031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocyte depleted Hodgkin lymphoma: an evaluation with immunophenotyping and genetic analysis.
    Slack GW; Ferry JA; Hasserjian RP; Sohani AR; Longtine JA; Harris NL; Zukerberg LR
    Leuk Lymphoma; 2009 Jun; 50(6):937-43. PubMed ID: 19455461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Hodgkin's disease: an update on histopathological and immunophenotypical features.
    Fraga M; Forteza J
    Histol Histopathol; 2007 Aug; 22(8):923-35. PubMed ID: 17503349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD15, CD30, and PAX5 evaluation in Hodgkin's lymphoma on fine-needle aspiration cytology samples.
    Cozzolino I; Vitagliano G; Caputo A; Montella M; Franco R; Ciancia G; Selleri C; Zeppa P
    Diagn Cytopathol; 2020 Mar; 48(3):211-216. PubMed ID: 31825183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMA monoclonal antibody is a superior anti-CD15 reagent for the diagnosis of classical Hodgkin's lymphoma?
    Pellegrini W; Bresciani G; De Zorzi A; Marocolo D; Ungari M; Facchetti F
    Haematologica; 2007 May; 92(5):708-9. PubMed ID: 17488702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of viable Hodgkin and Reed-Sternberg cells from Hodgkin disease tissues.
    Irsch J; Nitsch S; Hansmann ML; Rajewsky K; Tesch H; Diehl V; Jox A; Küppers R; Radbruch A
    Proc Natl Acad Sci U S A; 1998 Aug; 95(17):10117-22. PubMed ID: 9707610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal involvement by cutaneous CD30-positive T-cell lymphoma mimicking classical Hodgkin lymphoma.
    Eberle FC; Song JY; Xi L; Raffeld M; Harris NL; Wilson WH; Pittaluga S; Jaffe ES
    Am J Surg Pathol; 2012 May; 36(5):716-25. PubMed ID: 22367293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive overexpression of a novel 21 kDa protein by Hodgkin lymphoma and aggressive non-Hodgkin lymphomas.
    Zhou M; Fadlelmola FM; Cohn JB; Skinnider B; Gascoyne RD; Banerjee D
    Mol Cancer; 2008 Jan; 7():12. PubMed ID: 18218123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hodgkin's and Reed-Sternberg cells in the peripheral blood of a patient with advanced stage Hodgkin's disease].
    Milosević R; Colović M; Cemerikić-Martinović V; Colović N; Bogunović M
    Srp Arh Celok Lek; 2003; 131(9-10):400-2. PubMed ID: 15058220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell variant of classical Hodgkin's lymphoma with nodal and cutaneous manifestations demonstrated by single-cell polymerase chain reaction.
    Willenbrock K; Ichinohasama R; Kadin ME; Miura I; Terui T; Meguro K; Fukuhara O; DeCoteau JF; Hansmann ML
    Lab Invest; 2002 Sep; 82(9):1103-9. PubMed ID: 12218070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases.
    Loo EY; Medeiros LJ; Aladily TN; Hoehn D; Kanagal-Shamanna R; Young KH; Lin P; Bueso-Ramos CE; Manning JT; Patel K; Thomazy V; Brynes RK; Goswami M; Fayad LE; Miranda RN
    Am J Surg Pathol; 2013 Aug; 37(8):1290-7. PubMed ID: 23774171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of an expanded immunohistochemical panel to distinguish cutaneous Hodgkin lymphoma from histopathologic imitators.
    Cho RJ; McCalmont TH; Ai WZ; Fox LP; Treseler P; Pincus LB
    J Cutan Pathol; 2012 Jun; 39(6):651-8. PubMed ID: 22324490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease.
    Hansmann ML; Fellbaum C; Hui PK; Lennert K
    Histopathology; 1989 Jul; 15(1):35-48. PubMed ID: 2548946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic impact of tumour-associated macrophages and Reed-Sternberg cells in paediatric Hodgkin lymphoma.
    Gupta S; Yeh S; Chami R; Punnett A; Chung C
    Eur J Cancer; 2013 Oct; 49(15):3255-61. PubMed ID: 23791542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry of Hodgkin and non-Hodgkin lymphomas with emphasis on the diagnostic significance of the BNH9 antibody reactivity with anaplastic large cell (CD30 positive) lymphomas.
    Carbone A; Gloghini A; Volpe R
    Cancer; 1992 Dec; 70(11):2691-8. PubMed ID: 1330287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
    Vandenberghe P; Wlodarska I; Tousseyn T; Dehaspe L; Dierickx D; Verheecke M; Uyttebroeck A; Bechter O; Delforge M; Vandecaveye V; Brison N; Verhoef GE; Legius E; Amant F; Vermeesch JR
    Lancet Haematol; 2015 Feb; 2(2):e55-65. PubMed ID: 26687610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD30, CD15, CD50, and PAX5 Expressions as Diagnostic Markers for Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL).
    Ranuhardy D; Suzanna E; Sari RM; Hadisantoso DW; Andalucia R; Abdillah A
    Acta Med Indones; 2018 Apr; 50(2):104-109. PubMed ID: 29950528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells?
    Bellan C; Lazzi S; Zazzi M; Lalinga AV; Palummo N; Galieni P; Marafioti T; Tonini T; Cinti C; Leoncini L; Pileri SA; Tosi P
    Diagn Mol Pathol; 2002 Mar; 11(1):2-8. PubMed ID: 11854595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathological diagnosis of Hodgkin lymphoma].
    Tamaru J
    Nihon Rinsho; 2014 Mar; 72(3):450-5. PubMed ID: 24724402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.